The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J07 | Vaccines | |
| 3 | J07B | Viral vaccines | |
| 4 | J07BK | Varicella zoster vaccines | |
| 5 | J07BK02 | Zoster, live attenuated |
| Active Ingredient | Description | |
|---|---|---|
| Attenuated varicella-zoster virus |
Varicella-zoster virus vaccine was shown to boost VZV-specific immunity, which is thought to be the mechanism by which it protects against zoster and its complications. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ZOSTAVAX Powder and solvent for suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
